Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2) [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study (BALSAM-2) evaluating the efficacy and safety of KarXT for manic episodes in Bipolar I disorder, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• KarXT (xanomeline-trospium)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Bipolar Disorder Type I With Mania or Mania With Mixed Features | Phase 3 | Status: RECRUITING